Normal, marginal, and central ischemic regional myocardial function were evaluated in a canine model of myocardial infarction during 90 minute left circumflex coronary artery occlusion in 25 anesthetized dogs randomly assigned to intravenous ibuprofen infusion (n = 13,5.36 mg/kg/h beginning 1 hour before occlusion) or vehicle solution as control (n = 12) and in 15 conscious, unsedated dogs 48 and 72 hours after 90 minute circumflex artery occlusion followed by reperfusion (ibuprofen, 5.36 mg/kg/h by intravenous infusion over 7 hours beginning 1 hour before occlusion, n = 7; or vehicle solution infusion as control, n = 8).
Normal, marginal, and central ischemic regional myocardial function were evaluated in a canine model of myocardial infarction during 90 minute left circumflex coronary artery occlusion in 25 anesthetized dogs randomly assigned to intravenous ibuprofen infusion (n = 13,5.36 mg/kg/h beginning 1 hour before occlusion) or vehicle solution as control (n = 12) and in 15 conscious, unsedated dogs 48 and 72 hours after 90 minute circumflex artery occlusion followed by reperfusion (ibuprofen, 5.36 mg/kg/h by intravenous infusion over 7 hours beginning 1 hour before occlusion, n = 7; or vehicle solution infusion as control, n = 8).
Miniature subendocardial sonomicrometer crystal pairs were used to calculate left ventricular regional end-diastolic segment length, end-systolic segment length, and regional percent systolic shortening. Infarct size was estimated in 72 hour animals by a postmortem dual perfusion technique using triphenyltetrazolium histochemical dye and Evan's blue dye for determination of infarct area, risk area, and area not at risk. Ibuprofen treatment significantly reduced infarct size expressed as percent of risk area (mean f standard deviation of 44.6 f 18 versus 64.4 f 16% for control dogs, p <0.05) but it did not improve normal, marginal, or ischemic region end-diastolic length, end-systolic length or percent systolic shortening during coronary occlusion in anesthetized dogs or after reperfusion in conscious animals at 48 and 72 hours, and it did not enhance inotropic reserve at 72 hours in conscious animals. During 90 minute circumflex occlusion in anesthetized dogs, ibuprofen was associated with increases in systemic arterial pressure and worsened ischemic regional percent systolic shortening.
Thus, ibuprofen does not improve normal, marginal, or ischemic zone regional myocardial function during acute ischemia or 48 or 72 hours after myocardial reperfusion despite a significant reduction of infarct size.
Reducing the extent of ischemic injury has been proposed as a rational goal in the management of acute myocardial infarction.' Initial attempts to achieve this goal centered primarily on hemodynamic interventions which lessened myocardial oxygen consumption or improved blood flow or oxygen delivery to ischemic Ibuprofen infusion: Crystalline ibuprofen (sodium salt) was dissolved in 0.2 M sodium carbonate and adjusted to a pH of 8 by 1.0 N HCl. Solutions were mixed fresh before each experiment and diluted to 50 ml in physiologic saline solution. The ibuprofen dose employed was 5.36 mg/kg/h (7.14 ml/h of ibuprofen solution) by continuous intravenous infusion beginning 1 hour before occlusion and continuing throughout occlusion (90 minutes). This dose is similar to that used in a previous investigation6
with the exception of initiation of the infusion before occlusion in the present study. Vehicle solution prepared in an identical manner without ibuprofen served as a control.
A Harvard infusion pump was used to provide a constant infusion rate. Animals were randomly assigned to their treatment groups (13 ibuprofen, 12 control). A lead II electrocardiogram was monitored throughout the experiment.
After instrumentation, visible epicardial arterial anastomoses between the left anterior descending and circumflex coronary arteries were ligated to eliminate potentially large collateral routes of blood flow.'O A subtotal left circumflex coronary artery stenosis was produced just distal to the left atria1 appendage by tying 1-O silk suture around both the artery and an 18 gauge needle followed by immediate needle removal; subsequent total circumflex artery occlusion was performed after 10 minutes with a total duration of occlusion of 90 minutes. Three mg/kg of intravenous lidocaine and 3 mg/kg of intramuscular lidocaine were administered at the time of coronary artery occlusion as antiarrhythmic therapy." Approximately one fourth of the animals developed ventricular fibrillation during coronary occlusion, which was readily converted to sinus rhythm within 30 to 60 seconds by low energy (10 to 20 J) direct. current cardioversion using epicardial paddles. No myocardial dysfunction has been reported at these energy levels.12
Regional myocardial segment length: Measurement of regional myocardial segment length was obtained by converting sonomicrometer crystal transit time in microseconds to distance in millimeters using a known value for the velocity of ultrasound in myocardium at the frequency employed: Distance (mm) = transit time (I.CS) X ultrasound velocity in myocardium (1.58 mm/ps).l3 Before occlusion, end-diastolic length was defined in each segment as the maximal crystal separation in millimeters before the onset of the carotid artery systolic pressure rise, and end-systolic length was defined as the minimal crystal separation in millimeters before the dierotic notch of the carotid artery pressure tracing. Nonsimultaneous end-diastolic or end-systolic timing in marginal or ischemic segments in relation to normal segments was noted before occlusion and used as a reference to determine enddiastole and end-systole in the presence of dyskinesia during coronary artery occlusion.
Measurement of absolute enddiastolic and end-systolic length in millimeters were obtained and regional percent systolic shortening defined as end-diastolic minus end-systolic length divided by end-diastolic length X100%. Subendocardial crystal placement was confirmed by postmortem examination. A Grass model 7 polygraph was used to record measurements at a paper speed of 100 mm/s. Determination of carotid artery pressure, heart rate, and regional segment lengths and percent systolic shortening were obtained before and at the end of 90 minutes of coronary occlusion. All measurements were obtained at end-expiration and when the animal was free of arrhythmias.
Regional Myocardial Function 48 and 72 Hours After Coronary Artery Occlusion-Reperfusion
The effect of ibuprofen on regional myocardial function and infarct size was evaluated in conscious, unsedated dogs after left circumflex coronary artery occlusion with subsequent myocardial reperfusion in the anesthetized state. Fifteen healthy male mongrel dogs weighing 13.6 + 1.5 kg (range 10.2 to 15.8) were used. Instrumentation, baseline regional function measurements, and 90 minute circumflex occlusion followed by reperfusion were performed using aseptic technique in pentobarbital anesthetized, open-chest dogs as in the acute occlusion study. Animals were randomly assigned to either ibuprofen (n = 7) or vehicle as control (n = 8). Solutions were prepared as before and administered intravenously by Harvard infusion pump over 7 hours beginning 1 hour before occlusion with an ibuprofen dose of 5.36 mg/kg/h (7.14 ml/h of ibuprofen solution) or with an identical volume of vehicle as a control. Ischemic zone sonomicrometer crystals were associated with greater postoperative mortality in preliminary studies and therefore implanted in only 4 animals in each group. As in the acute occlusion study, a critical circumflex stenosis was placed 10 minutes before total occlusion using an 18 gauge needle and 1-O silk suture. A Carolina Medical Electronics electromagnetic flow probe was placed around the circumflex artery proximal to the subtotal occlusion to document a critical stenosis (defined as a stenosis causing at least a 50% reduction in peak reactive hyperemic flow after 10 seconds of coronary occlusion without altering basal flow or sonomicrometer crystal segment length). This subtotal critical stenosis was left in place throughout the remainder of the experiment (until the animals were killed at 72'hours).
Coronary occlusion and reperf!sion:
Total left circumflex occlusion was performed using soft plastic tape for 90 minutes and the occlusion was slowly released over 5 to 10 minutes. Intravenous lidocaine, 3 mg/kg, was administered on reperfusion.
Reperfusion occurred in all animals as documented by 3 or more of the following criteria: (1) the onset of ventricular arrhythmias within 15 to 30 minutes of occlusion release; (2) a decrease in marginal and ischemic region enddiastolic and end-systolic segment length on release of the occlusion; (3) at least 5 ml/min of circumflex artery flow on occlusion release documented by electromagnetic flow probe; and (4) the absence of visible coronary artery thrombosis at 72 hours when the animal was killed.
After reperfusion, the chest was closed and the animals were allowed to recouer. systolic shortening with paradoxic systolic expansion (dyskinesia).
Heart rate was not altered by ibuprofen during coronary occlusion; however, mean carotid artery pressure rose significantly with a rise in pressure-rate product (the product of mean arterial pressure and heart rate divided by 100) ( Table I) .
Regional myocardial function 48 and 72 hours after coronary artery occlusion-reperfusion: Serial changes in regional myocardial function in a control animal before, during, and up to 72 hours after coronary artery occlusion-reperfusion are shown in Figure 3 T T
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RhrS 72 hrs wifh lmtropic &ant FIGURE 4. Effect of ibuprofen on normal zone regional myocardial function before circumflex occlusion and in conscious, unsedated animals at 48 and 72 hours and with inotropic stimulation at 72 hours. No significant differences were present between groups (analysis of variance for repeated measures). IV = intravenous; SD = standard deviation. 
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The American Journal of CARDIOLOGY Volume 50 853 (Table I) without an effect on heart rate after 90 minutes of coronary occlusion. This result, not found in previous investigations employing different models of ischemia and different drug administration schedules, would increase rather than decrease myocardial oxygen consumption and thus tend to worsen ischemic injury.21 In addition, directly measured myocardial oxygen consumption is not altered by ibuprofen administration during 60 minutes of normothermic global ischemia in the isolated, bloodperfused feline heart.i5
Increased blood flow to ischemic tissue by direct coronary artery vasodilation or enhanced collateral blood flow is also an unlikely mechanism of ibuprofen's beneficial effect. Tracer microsphere studies in experimental myocardial infarction have failed to demonstrate increased blood flow to ischemic tissue up to 6 hours6 or 24 hours15 after coronary occlusion in ibuprofen-treated experimental animals.
An antithrombotic effect of ibuprofen is a 2nd possible mechanism by which ibuprofen may reduce infarct size.7 In the present study, however, coronary artery reperfusion occurred in all animals and only 1 of 8 control animals developed visible thrombus at 72 hour postmortem examination. Also, the antithrombotic agent sulfinpyrazone does not appear to reduce infarct size.22 Thus, it is improbable that an antithrombotic effect of ibuprofen played a role in the present study. The potentially related phenomenon of platelet deposition at the site of ischemic injury also occurs in myocardial infarction and is diminished by aspirin.23 Ibuprofen, however, does not alter indium-111-labeled platelet accumulation in the ischemic myocardium.2" A 3rd possible mechanism by which ibuprofen may exert a myocardial protective effect is its antiinflammatory action, related to inhibition of the arachidonic acid pathway." Cyclooxygenase enzyme inhibition could have a beneficial effect in ischemic tissue through a reduction in the synthesis of thromboxane, a potent vasoconstrictor. However, other nonsteroidal cyclooxygenase inhibitors do not reduce the extent of experimental ischemic injury.zsJsJe An alternative hypothesis also related to the arachidonic acid cascade which may in part explain ibuprofen's beneficial effect in myocardial ischemia is inhibition of the lipoxygenase pathway. This branch of'the arachidonic acid cascade is capable of producing powerful chemotactic substances (hydroxyeicosatetraenoic acid [HETE] derivatives) and leukotrienes, which are additional mediators of the inflammatory response.27 Ibuprofen has been shown to inhibit the synthesis of 12-HETE, catalyzed by a putative peroxidase enzyme.zs Lipoxygenase pathway inhibition may in part account for ibuprofen's ability to inhibit the migration of polymorphonuclear leukocytes,2g an effect noted with ibuprofen in experimental myocardial ischemia.24
A 4th mechanism of potential significance in explaining ibuprofen's myocardial protective action is inflammatory cell lysosomal membrane stabilization, an effect suggested by data from noncardiac in vitro preparationsa0-:s2 and by indirect evidence in canine cardiac ischemia.4 In addition, ibuprofen affects kinin and histamine release2 and superoxide radical forma- which may in part account for its anti-inflammatory effect.
The use of lidocaine in our study could also reduce the severity of myocardial ischemic injury.35 Our data, however, indicate extensive infarction despite lidocaine administration and an additional beneficial effect of ibuprofen if lidocaine myocardial preservation occurred.
Discordance
between infarct size reduction and functional recovery: The discrepancy between myocardial infarct size and functional recovery in this investigation may be due to several factors. Improvement in regional myocardial function may occur at a time not evaluated in this study. A functionally beneficial effect of ibuprofen between the onset of reperfusion and 48 hours cannot be excluded; in the present study a functional assessment was not performed during that time because of marked beat-to-beat segment length changes associated with frequent reperfusion arrhythmias. Alternatively, improvement in myocardial function with ibuprofen could occur at a time later than 72 hours. This possibility is supported by sonomicrometer crystal data in conscious dogs studied up to 4 weeks after 2 hour coronary artery occlusion.20 Substantial recovery of marginal and ischemic segment systolic shortening occurred 1 to 4 weeks after coronary artery occlusionreperfusion. Further studies will be necessary to determine whether ibuprofen treatment alters regional myocardial function more than 3 days after myocardial infarction.
Improvement in indexes of myocardial function
other than subendocardial segment length changes is another possible explanation of the discordance between infarct size reduction and functional recovery in this investigation. Roan et a1.36 noted spontaneous improvement in ischemic zone ventricular wall paradoxic systolic thinning between 24 hours and 1 week after coronary artery occlusion. Other measures of regional function which were not evaluated in this study include mid-myocardial and subepicardial segment length changes, which may have been altered more than subendocardial functional measurements in view of predominant subepicardial tissue salvage by gross inspection.
A persistent inability of ibuprofen to significantly improve marginal or ischemic region myocardial function despite infarct size reduction as determined by histochemical staining is also possible. Glucocorticoids have been implicated in "mummification" of ischemic myocardium (loss of nuclei with intact myofibril striations and sarcolemma).37 Such tissue may retain the ability to stain dehydrogenase with triphenyltetrazolium despite the loss of functional integrity. The absence of such a "mummification" effect on light microscopic evaluation in this investigation provides evidence against that possibility.
A recent publication by Kloner et a1.38 demonstrated that a 15 minute period of coronary occlusion followed by reperfusion, which is not associated with the development of necrosis, nonetheless results in prolonged biochemical, functional, and ultrastructural abnormalities. Wall motion, as determined by ultrasonic IBUPROFEN AND REGIONAL MYOCARDIAL FUNCTION-KIRLIN ET AL crystal measurements, was still reduced at 3 days of reperfusion, whereas creatine phosphate levels and regional myocardial blood flow recovered rapidly and had returned to normal after 90 minutes of coronary reperfusion.
Brief periods (15 minutes) of regional ischemia followed by full reperfusion, therefore, can be associated with abnormalities in cardiac contractile function which persist for a relatively long period. Bush et al.sg showed that the biochemical abnormalities associated with regional ischemia after reperfusion also extend to the normally perfused myocardium.
Thus, a regional ischemic event may produce an influence on a remote region of myocardium which may persist for several days after the restoration of coronary blood flow.383 9.
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In the present investigation, coronary artery occlusion was maintained for 90 minutes and was followed by reperfusion in the presence of a critical stenosis. It is conceivable that the failure of the salvaged myocardial segment to regain contractile function could be related to the relatively persistent derangement in segment length shortening which is seen even in the absence of cellular necrosis. Future attempts to assess the potential benefits of pharmacologic interventions in protecting ischemic myocardium should consider the functional recovery of the "salvaged" myocardium days to weeks after the ischemic episode.
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Implications:
Intravenous ibuprofen infusion reduces myocardial infarct size without improving normal, marginal, or ischemic region myocardial function during coronary artery occlusion or 48 or 72 hours after myocardial reperfusion, or inotropic reserve at 72 hours. Further studies are necessary to assess ibuprofen's effect on regional myocardial function at intervals greater than 72 hours after myocardial infarction and to further elucidate the mechanisms by which ibuprofen exerts a protective effect on ischemic myocardial tissue.
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